Alison A. Armour

Alison A. Armour discloses dealings in Endocyte Inc to SEC (Form 4). In total, 19 filings cover trades dated from 4 February 2016 to 21 December 2018.

Every open-market trade on record is a sale: 2 sales worth €142k. Besides market trades, the filings include 5 share grants and 3 option exercises. So far in 2018, the count stands at no purchases and 2 sales.

The latest filing, published on 21 December 2018, reports a transaction of €1.5M in Endocyte Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.